Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

NeuroAIDS in Brazil.

Ronald J Ellis1, Jeymohan Joseph, Ségio Montiero de Almeida

  • 1Department of Neurosciences, HIV Neurobehavioral Research Center, University of California, San Diego, San Diego, California 92103, USA. roellis@UCSD.edu

Journal of Neurovirology
|May 17, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

HIV-1 soluble gp120 in cerebrospinal fluid is associated with poorer motor domain neurocognitive performance in virally suppressed people with HIV.

AIDS (London, England)·2026
Same author

Compartmentalized biomarker correlations in HIV: plasma-CSF relationships vary by blood-brain/blood-CSF barrier permeability and viral suppression.

Scientific reports·2026
Same author

CMV IgG and EBV Cell-Associated DNA Independently Associate With Veterans Aging Cohort Study (VACS) Index 2.0 Scores in People With HIV on Antiretroviral Therapy.

The Journal of infectious diseases·2026
Same author

Distinct roles of dopamine receptors in HIV latency reversal in a myeloid cell model.

Frontiers in immunology·2026
Same author

Central Nervous System T-cell immune architecture, and not HIV burden, tracks with cognition under long-term viral suppression.

PLoS pathogens·2026
Same author

Compartmentalized Biomarker Correlations in HIV: Plasma-CSF Relationships Vary by Blood-Brain/Blood-CSF Barrier Permeability and Viral Suppression.

Research square·2026

Brazil faces a significant burden of Human Immunodeficiency Virus (HIV) with over 600,000 cases. Recent expert meetings focused on understanding and addressing the neurological complications associated with HIV in the country.

Area of Science:

  • Neurology
  • Infectious Diseases
  • Public Health

Background:

  • Brazil has the highest number of Human Immunodeficiency Virus (HIV) cases in Latin America, exceeding 600,000.
  • Neurological complications represent a significant aspect of HIV morbidity in Brazil.
  • There is a growing need to characterize the extent of neurological issues in Brazilian HIV patients.

Purpose of the Study:

  • To summarize existing knowledge on HIV and its neurological complications in Brazil.
  • To identify key areas for future research in neuro-HIV in Brazil.
  • To foster collaboration among experts in the field.

Main Methods:

  • Convened two expert meetings cosponsored by the U.S. National Institute of Mental Health in 2005 and 2006.
  • Facilitated discussions covering clinical neurobehavioral aspects to molecular biology of HIV.

Related Experiment Videos

  • Synthesized expert opinions on the current state of neuro-HIV research in Brazil.

    • Main Results:

    • Identified a substantial knowledge base regarding HIV's neurological impact in Brazil.
    • Highlighted the diverse range of neurological manifestations associated with HIV.
    • Established a consensus on critical research gaps and future directions.

    Conclusions:

    • Further research is crucial to fully understand and manage HIV-related neurological morbidity in Brazil.
    • Collaborative efforts are needed to advance the field of neuro-HIV in the Brazilian context.
    • Future research should encompass clinical, epidemiological, and molecular aspects of neuro-HIV.